MycoBiomDB – Record Details (MyCo_1335)

Biomarker Record Details

Database ID: MyCo_1335
DB IDMyCo_1335
TitleClinical evaluation of diagnostic methods using plasma and/or serum for three mycoses: aspergillosis, candidosis, and pneumocystosis
Year1999
PMID10536309
Fungal Diseases involvedInvasive candidiasis
Associated Medical ConditionNone
GenusCandida
Speciesspp.
OrganismCandida spp.
Ethical StatementNone
Site of InfectionNone
Opportunistic invasiveInvasive
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameBDG
Biomarker Full Name1-3-beta-D-Glucan
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationJapan
Cohort8 patients with invasive aspergillosis, 3 with aspergilloma, 9 with candidosis, 4 with pneumocystosis, and 15 with no fungal infections, were included in the study.
Cohort No.24 Patients and 15 control
Age GroupNone
P ValueNone
Sensitivity0.688
Specificity0.571
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismNone
TechniqueImmunological assay
Analysis MethodCAND-TEC test
ELISA kitsBDG kinetic chromogenic Limulus method Kit (FUNGITEC(R) G test MK [Seikagaku Corp. Tokyo, Japan]), BDG kinetic turbidimetric Limulus method Kit (B-glucan test Wako [Wako Pure Chemical Industries, Ltd., Osaka, Japan]), BDG Pastorex(R) Aspergillus test (the Pastorex(R)), Pastorex(R), BDG Candida test Kit (Diagnostic Pasteur, Paris, France), BDG CAND-TEC(R) test Kit (Ramco Laboratories, Inc., Houston, USA)
Assay DataNone
Validation Techniques usedBDG chromogenic Analysis, BDG Wako turbidimetric Analysis, Pastorex Candida test, CAND-TEC test
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone